You are currently browsing the archives for 30 January 2018.
Displaying 1 entry.

Bend Research extends 3-year contract with Bristol-Myers Squibb Bend Research Inc.

, a worldwide biopharmaceutical company. Beneath the conditions of the 3-12 months agreement, Bristol-Myers Squibb use Bend Research’s formulation advancement and manufacturing providers for preclinical and medical development. Bend Research may also manufacture drug item intermediates and drug items in its current Great Manufacturing Practice service for Bristol-Myers Squibb medical trials. In the collaboration, both companies use their complementary fundamental scientific capabilities to resolve complex process-advancement and formulation challenges. ‘We have become excited to increase our working contract with Bristol-Myers Squibb also to combine the data and connection with our two businesses,’ stated Rod Ray, Bend Analysis CEO. ‘We talk about a committed action to applying fundamental research and engineering to the delivery of fresh medicines that may enhance patients’ lives.